Nature's Sunshine Products, Inc. Stock

Equities

NATR

US6390271012

Food Processing

Market Closed - Nasdaq 04:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
19.52 USD -1.26% Intraday chart for Nature's Sunshine Products, Inc. +3.77% +12.90%
Sales 2024 * 468M Sales 2025 * 496M Capitalization 367M
Net income 2024 * 16M Net income 2025 * 18M EV / Sales 2024 * 0.59 x
Net cash position 2024 * 92.7M Net cash position 2025 * 102M EV / Sales 2025 * 0.53 x
P/E ratio 2024 *
23.2 x
P/E ratio 2025 *
20.3 x
Employees 814
Yield 2024 *
-
Yield 2025 *
-
Free-Float 78.7%
More Fundamentals * Assessed data
Dynamic Chart
DA Davidson Raises Nature's Sunshine Products' Price Target to $24 From $21.50, Maintains Buy Rating MT
Tranche Update on Nature's Sunshine Products, Inc.'s Equity Buyback Plan announced on March 10, 2021. CI
Nature's Sunshine Products, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : Nature's Sunshine Products, Inc., Q4 2023 Earnings Call, Mar 12, 2024
Earnings Flash (NATR) NATURE'S SUNSHINE PRODUCTS Reports Q4 EPS $0.45 MT
Earnings Flash (NATR) NATURE'S SUNSHINE PRODUCTS Posts Q4 Revenue $108.9M, vs. Street Est of $111.1M MT
Nature's Sunshine Products, Inc. Provides Earnings Guidance for the Full Year 2024 CI
Nature's Sunshine Products, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Natures Sunshine Products Insider Sold Shares Worth $256,960, According to a Recent SEC Filing MT
Tranche Update on Nature's Sunshine Products, Inc.'s Equity Buyback Plan announced on March 10, 2021. CI
Nature's Sunshine Products, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : Nature's Sunshine Products, Inc., Q3 2023 Earnings Call, Nov 07, 2023
Earnings Flash (NATR) NATURE'S SUNSHINE PRODUCTS Reports Q3 Revenue $111.2M, vs. Street Est of $110.2M MT
Earnings Flash (NATR) NATURE'S SUNSHINE PRODUCTS Posts Q3 GAAP EPS $0.15, vs. Street Est of $0.13 MT
Nature's Sunshine Products, Inc. Provides Earnings Guidance for the Full Year 2023 CI
More news

Latest transcript on Nature's Sunshine Products, Inc.

1 day-1.26%
1 week+3.77%
Current month-6.02%
1 month-1.11%
3 months+12.31%
6 months+4.61%
Current year+12.90%
More quotes
1 week
18.73
Extreme 18.73
19.83
1 month
18.40
Extreme 18.4
21.22
Current year
16.79
Extreme 16.79
21.72
1 year
10.06
Extreme 10.06
21.72
3 years
7.93
Extreme 7.93
21.72
5 years
5.50
Extreme 5.5
21.72
10 years
5.50
Extreme 5.5
21.72
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 18-09-24
Director of Finance/CFO 53 22-12-18
Sales & Marketing 41 23-10-29
Members of the board TitleAgeSince
Chairman 66 18-05-24
Director/Board Member 53 17-06-07
Chief Executive Officer 61 18-09-24
More insiders
Date Price Change Volume
24-04-24 19.52 -1.26% 37,071
24-04-23 19.77 +1.85% 25,044
24-04-22 19.41 +0.62% 46,942
24-04-19 19.29 +3.16% 47,213
24-04-18 18.7 -0.58% 53,531

Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT

More quotes
Nature's Sunshine Products, Inc. is a natural health and wellness company, which markets and distributes nutritional and personal care products in more than 40 countries. The Company sells its products to a sales force of independent consultants who use the products themselves or resells them to consumers. The Company has four segments: Asia, Europe, North America, and Latin America and Other. Each of the geographic segments operates under the Natures Sunshine Products and Synergy WorldWide brands. The Latin America and Other segment include its wholesale business, in which the Company sells products to various locally managed entities, independent of the Company, that it has granted distribution rights for the relevant market. The Company's line of over 800 products includes several different product classifications, such as immune, cardiovascular, digestive, personal care, weight management and other general health products. It purchases herbs and other raw materials in bulk.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
19.52 USD
Average target price
24 USD
Spread / Average Target
+22.95%
Consensus